Bartizal Ken 4
4 · Trius Therapeutics Inc · Filed May 16, 2013
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2013-05-14$7.85/sh−12,000$94,200→ 98,927 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 271 shares, 347 shares and 465 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 11/18/11, 5/18/12 and 11/20/12, respectively.